Treatment of Iron Deficiency Anemia (IDA)
Oral iron supplementation is the first-line treatment for most patients with iron deficiency anemia, with ferrous sulfate 200 mg twice daily being the most effective and economical option to correct anemia and replenish iron stores. 1
Initial Treatment Approach
- All patients with IDA should receive iron supplementation to correct anemia and replenish body stores, regardless of the underlying cause 1
- First-line therapy is oral ferrous sulfate 200 mg twice daily (contains approximately 65 mg elemental iron per tablet) 1
- Alternative oral iron formulations may be better tolerated in some patients:
- Lower doses of oral iron may be as effective and better tolerated than traditional doses 1
Duration of Treatment
- Oral iron should be continued for 3 months after correction of anemia to ensure iron stores are fully replenished 1
- Hemoglobin concentration should rise by approximately 2 g/dL after 3-4 weeks of proper treatment 1
- Failure to respond suggests poor compliance, misdiagnosis, continued blood loss, or malabsorption 1
Adjunctive Therapies
- Ascorbic acid (250-500 mg twice daily) taken with iron supplements may enhance iron absorption when response to iron therapy is poor 1
- Treatment of any underlying cause (e.g., gastrointestinal bleeding, celiac disease) should be addressed simultaneously to prevent further iron loss 1
Intravenous Iron Therapy
Intravenous (IV) iron should be considered in the following situations:
- Intolerance to at least two oral iron preparations 1
- Non-compliance with oral therapy 1
- Patients with inflammatory bowel disease and active inflammation with compromised absorption 1
- Patients with portal hypertensive gastropathy and ongoing bleeding who don't respond to oral iron 1
- Severe iron deficiency requiring rapid repletion 2
Available IV iron preparations include:
- Iron sucrose (Venofer) - can be administered as 200 mg over 10 minutes 1, 3
- Ferric carboxymaltose (Ferinject) - can deliver up to 1000 mg in a single 15-minute infusion 1
- Iron dextran (Cosmofer) - can be given IV or IM, but carries higher risk of serious reactions 1
Special Populations
- Inflammatory Bowel Disease: IV iron therapy is preferred in patients with active inflammation due to compromised absorption of oral iron 1
- Portal Hypertensive Gastropathy: Start with oral iron, but switch to IV iron if there's ongoing bleeding without response to oral therapy 1
- Celiac Disease: Ensure adherence to a gluten-free diet to improve iron absorption; consider IV iron if stores don't improve with oral therapy 1
- Small-bowel Angioectasias: Iron replacement (oral or IV depending on severity) should accompany endoscopic treatment 1
Monitoring and Follow-up
- Monitor hemoglobin concentration and red cell indices at regular intervals:
- Every 3 months for the first year after correction
- Then after a further year 1
- Additional oral iron should be given if hemoglobin or MCV falls below normal 1
- Further investigation is only necessary if hemoglobin and MCV cannot be maintained with supplementation 1
Common Pitfalls and Caveats
- Failure to continue iron therapy for 3 months after normalization of hemoglobin leads to inadequate replenishment of iron stores 1
- Accepting upper GI findings like erosions or peptic ulcers as the sole cause of IDA without investigating the lower GI tract (dual pathology occurs in 10-15% of patients) 1
- Overlooking poor compliance due to gastrointestinal side effects of oral iron 1
- Parenteral iron therapy should not be used routinely due to higher cost and risk of adverse reactions, including rare but serious anaphylactic reactions 1
- Transfusions should be avoided in chronically anemic patients due to potential side effects and cost, and reserved only for hemodynamically unstable patients 4